Targeting Hypervigilance and Autonomic Arousal: the Psycho-physiologic Model of Gastroesophageal Reflux Disease (GERD)
NCT04960566 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2025-08-11
Summary
GERD affects roughly 20% of the U.S. population and the direct and indirect costs of GERD are substantial, totaling close to 50 billion dollars per year. Evidence supports that a large proportion of this cost and poor clinical outcomes in GERD are related to poor healthcare decisions by both the physician and the patient. The problem of inappropriate GERD management stems from three main issues. First, the disease is heterogeneous and requires treatment informed by a precision model. Second, the current paradigm largely ignores the important brain-gut interactions that drive symptoms and healthcare utilization. Third, there is a paucity of well-performed comparative effectiveness trials focused on assessing treatments beyond acid suppression. We will use physiomarkers defined during the previous funding cycle to phenotype the patients and use cognitive behavioral interventions to modulate hypervigilance to test the Psycho-Physiologic Model of GERD. Cognitive Behavioral Therapy (CBT) is able to improve hypervigilance and symptom specific autonomic arousal and thus, we will test our theory that CBT can improve outcomes in GERD by targeting these two important psychologic stressors. We will also continue our focus on the interplay of psychology and physiology by determining whether increased mucosal permeability is associated with reflux perception and whether this is modified by hypervigilance and autonomic disruption.
Conditions
- Gastroesophageal Reflux
Interventions
- OTHER
-
Cognitive Behavioral Therapy
The CBT intervention is based on the theoretical framework that under stress (reflux symptoms) a person makes a rapid cognitive appraisal of the potential threat (automatic thoughts), leading to both emotional and physical responses in the body, thereby reacting behaviorally (avoidance, increased HCU) in an attempt to mitigate unpleasantness. CBT is a collaborative, present-focused treatment that utilizes a skills-based approach with home practice exercises. CBT targets automatic thoughts and appraisals of threat via education, self-monitoring of stressors and symptoms, and strategies to reframe problematic thinking patterns to more adaptive ones. Resonance frequency breathing (RFB) is achieved when a person breathes at a pace, typically 4 to 6 breaths per minute, that engages the body's baroreflex to modulate arousal. Prior research demonstrates 4 to 6 weeks of RFB training is sufficient to significantly increase baseline HRV with enduring effects for up to 6 months.
- OTHER
-
Sham-SOC Lifestyle Coaching
Sham-SOC Lifestyle Coaching
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
Washington University School of Medicine
collaborator OTHER -
University of California, San Diego
collaborator OTHER -
Vanderbilt University School of Medicine
collaborator OTHER - lead OTHER
Principal Investigators
-
John E Pandolfino, MD · Northwestern University
-
Tifffany Taft, PsyD · Northwestern University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-19
- Primary Completion
- 2026-05-31
- Completion
- 2026-11-30
Countries
- United States
Study Locations
More Related Trials
-
The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Sensitivity in Healthy Volunteers
NCT02674256 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of MIST on Esophageal Sensitivity in Patients With rGERD
NCT05429034 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers
NCT02736734 ·Status: COMPLETED ·Phase: PHASE4
-
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT01472939 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Education in Gastroesophageal Reflux Disease
NCT00618150 ·Status: COMPLETED ·Phase: NA
-
Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease
NCT03619811 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy
NCT03596476 ·Status: RECRUITING ·Phase: NA
-
Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial
NCT02486263 ·Status: COMPLETED ·Phase: NA
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Predictors of Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease Patients
NCT01797939 ·Status: COMPLETED
-
Effectiveness of Physiologic Testing in PPI Non-Responders
NCT03202537 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Treatment of Newly Diagnosed Gastroesophageal Reflux Disease in a National Population-based Cohort
NCT03524781 ·Status: COMPLETED
-
Response to Supplement and Placebo in GERD
NCT01915173 ·Status: COMPLETED ·Phase: NA
-
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
NCT00260572 ·Status: ACTIVE_NOT_RECRUITING
-
A Comparison of Factors of Symptoms Generation and Evaluation of Role of Biofeedback in Patients With Different Types of Functional Esophageal Disorders (Functional Heartburn and Functional Chest Pain)
NCT00471796 ·Status: UNKNOWN ·Phase: NA
-
Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?
NCT01204931 ·Status: COMPLETED
-
Breathing Exercises in Patients With Gastroesophageal Reflux
NCT06812650 ·Status: COMPLETED ·Phase: NA
-
The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal Reflux
NCT00462137 ·Status: COMPLETED
-
Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of Smartphone Application GERDCare
NCT07127276 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare
NCT07125521 ·Status: RECRUITING ·Phase: NA
-
The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients
NCT02149914 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Gut-Brain Neuromodulators in the Treatment of Gastroesophageal Reflux Disease
NCT06945237 ·Status: COMPLETED ·Phase: NA
-
The Effect of Positional Therapy on Symptoms of Gastroesophageal Reflux Disease: A Prospective Pilot Study
NCT04500288 ·Status: UNKNOWN ·Phase: NA
-
Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux
NCT02972047 ·Status: COMPLETED ·Phase: NA
-
Treatment of Globus Sensations With Psychotherapy
NCT01590992 ·Status: COMPLETED ·Phase: NA